| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Sales | 0 | 55* | NaN | 0 |
| Service revenue | 0 | 0* | 0 | 0 |
| Cost of revenues | 0 | 43* | NaN | 0 |
| Gross profit | 0 | 12 | 0 | 0 |
| General and administrative | 31,335 | 22,907 | 25,795 | 28,200 |
| Total operating expenses | 31,335 | 22,907 | 25,795 | 28,200 |
| Operation income | -31,335 | -22,895 | -25,795 | -28,200 |
| Other income | 15,829 | NaN | NaN | NaN |
| Interest expense | 2,100 | 2,100 | 2,100 | 2,100 |
| Loss from inventory impairment | 0 | 174,745 | NaN | NaN |
| Income tax provision | 0 | 0 | 0 | 0 |
| Net loss | -17,606 | -199,740 | -27,895 | -30,300 |
| Diluted EPS | 0 | -0.002 | NaN | NaN |
| Diluted Average Shares | 99,000,000 | 104,133,334 | 96,433,333 | 96,433,333 |
GOLDENWELL BIOTECH, INC. (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL)